M13. Identifying Youths at Risk for Antipsychotic-Induced Weight Gain and Metabolic Dysfunction in the Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
Taylor J, Jakubovski E, Gabriel D, Bloch M. M13. Identifying Youths at Risk for Antipsychotic-Induced Weight Gain and Metabolic Dysfunction in the Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS). Schizophrenia Bulletin 2017, 43: s215-s216. PMCID: PMC5475770, DOI: 10.1093/schbul/sbx022.012.Peer-Reviewed Original ResearchEarly-onset schizophrenia spectrum disordersAntipsychotic-Induced Weight GainSchizophrenia spectrum disordersMetabolic dysfunctionWeight gainSpectrum disorder